Halcinonide topical Alternatives Compared
| Halcinonide topical | Dupixent (dupilumab) | Triamcinolone topical |
|
|---|
| Halcinonide topical | Dupixent (dupilumab) | Triamcinolone topical |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Eczema, Atopic Dermatitis, Dermatitis, Psoriasis. Halcinonide topical may also be used for purposes not listed in this medication guide. |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, or prurigo nodularis. Injection site reactions and eye problems... View more |
Prescription only
Prescribed for Lichen Planus, Atopic Dermatitis, Dermatitis, Aphthous Ulcer, Eczema, Psoriasis, Stomatitis, Allergies. Triamcinolone topical may also be used for purposes not listed in this medication guide. View more |
Related suggestions |
|||||||||||||||||||||||
| More about Halcinonide topical | More about Dupixent (dupilumab) | More about Triamcinolone topical | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Halcinonide topical has an average rating of 9.3 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Dupixent has an average rating of 7.2 out of 10 from a total of 498 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 20% reported a negative effect. |
Triamcinolone topical has an average rating of 7.7 out of 10 from a total of 106 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Halcinonide topical side effects |
View all Dupixent side effects |
View all Triamcinolone topical side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
N/A |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Halcinonide topical prices |
View all Dupixent prices |
View all Triamcinolone topical prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Halog |
N/A |
Aricin, Aristocort A, Aristocort R, Cinalog, Cinolar, Delta-Tritex, DermacinRx Silazone, DermacinRx Trizapak, Dermasorb TA, Juulissa Pharmapak, Kenalog, Kourzeq, Oralone, SilaLite Pak, Treziopak, Trianex, Triasil, Triderm, Tritocin View more | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 47 drugs are known to interact with Halcinonide topical:
|
A total of 91 drugs are known to interact with Dupixent:
|
A total of 48 drugs are known to interact with Triamcinolone topical:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
November 27, 1974 |
March 28, 2017 |
October 23, 1958 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.